Horizon Discovery Group plc Block listing Interim Review (2929O)

TIDMHZD

RNS Number : 2929O

Horizon Discovery Group plc

28 January 2019

Horizon Discovery Group plc

Block Listing Six Monthly Return and Block Listing Application

28 January 2019

Horizon Discovery Group plc (LSE: HZD) ("Horizon") provides the following update in accordance with Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:

 
 Name of applicant:                  Horizon Discovery Group plc 
 Name of scheme(s):                  a) Horizon Discovery Limited Enterprise 
                                      Management Incentive Share Option 
                                      Scheme 
                                      b) Horizon Discovery Group plc Long 
                                      Term Incentive Plan 
                                      c) Horizon Discovery 2014 Sharesave 
                                      Scheme 
                                      d) Horizon Discovery Group plc US 
                                      Employee Stock Purchase Plan 
                                    ------------------------------------------ 
 Period of return (from              From: 27 July         To: 25 January 
  / to):                              2018                  2019 
                                    --------------------  -------------------- 
 Number of securities admitted       Total of 3,000,000 ordinary shares 
  and date of admission               of 1p each, admission date 26 July 
                                      2017, split: 
                                      a) 1,398,000 
                                      b) 1,392,000 
                                      c) 110,000 
                                      d) 100,000 
                                      Further 500,000 ordinary shares 
                                      of 1p each, admission date 27 July 
                                      2018, split: 
                                      a) 0 
                                      b) 150,000 
                                      c) 150,000 
                                      d) 200,000 
                                    ------------------------------------------ 
 Balance of unallotted securities    Total of 2,575,857 ordinary shares 
  under schemes from previous         of 1p each, split 
  return:                             a) 778,536 
                                      b) 1,373,689 
                                      c) 157,777 
                                      d) 265,855 
                                    ------------------------------------------ 
 Plus: The amount by which 
  the block scheme(s) has 
  been increased or application 
  has been made to increase 
  since the date of the last 
  return (if any increase 
  has been applied for):             0 
                                    ------------------------------------------ 
 Less: Number of securities          Total of 819,433 ordinary shares 
  issued/allotted under scheme(s)     of 1p each, split 
  during period:                      a) 161,786 
                                      b) 447,669 
                                      c) 59,712 
                                      d) 150,266 
                                    ------------------------------------------ 
 Equals: Balance under scheme(s)     Total of 1,756,424 ordinary shares 
  not yet issued/allotted             of 1p each, split 
  at end of period:                   a) 616,750 
                                      b) 926,020 
                                      c) 98,065 
                                      d) 115,589 
                                    ------------------------------------------ 
 

ENDS

For further information from Horizon Discovery Group plc, please contact:

Horizon Discovery Group plc

Terry Pizzie, Chief Executive Officer

Richard Vellacott, Chief Financial Officer

Tel: [phone]

Numis Securities Limited (Broker and NOMAD)

Michael Meade / Freddie Barnfield

Tel: [phone]

Consilium Strategic Communications (Financial Media and Investor Relations)

Mary-Jane Elliott / Matthew Neal / Melissa Gardiner

Tel: [phone]

Email: [e-mail]

About Horizon Discovery Group plc www.horizondiscovery.com

Horizon Discovery Group plc (LSE: HZD) ("Horizon") is a world leader in gene editing and gene modulation technologies. Horizon designs and engineers cells using its translational genomics platform, a highly precise and flexible suite of DNA editing tools (rAAV, ZFN, CRISPR and Transposon) and, following the acquisition of Dharmacon, Inc., its functional genomics platform comprising gene knockdown (RNAi) and gene expression (cDNA, ORF) tools, for research and clinical applications that advance human health. Horizon's platforms and capabilities enable researchers to alter almost any gene or modulate its function in human or mammalian cell-lines.

Horizon offers an extensive range of catalogue products and related research services to support a greater understanding of the function of genes across all species and the genetic drivers of human disease and the development of personalised molecular, cell and gene therapies. These have been adopted by over 10,000 academic, drug discovery, drug manufacturing and clinical diagnostics customers around the globe, as well as in the Company's own R&D pipeline.

Horizon is headquartered in Cambridge, UK, and is listed on the London Stock Exchange's AIM market under the ticker "HZD".

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

BLRGMGZMZRDGLZM

(END) Dow Jones Newswires

January 28, 2019 07:08 ET (12:08 GMT)